Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription 23.12.2024 1 Am J Psychiatry 2 Biol Psychiatry 1 Br J Psychiatry 1 Can J Psychiatry 1 Cereb Cortex 1 J Clin Psychopharmacol 6 Mol Psychiatry 1 Nat Ment Health 6 Psychiatry Res 4 Psychol Med 9 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Psychiatry

1. HORAN WP, Sauder C, Harvey PD, Ramsay IS, et al
   The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.
   Am J Psychiatry. 2024 Dec 11. doi: 10.1176/appi.ajp.20240076.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

2. BUCK J, Horga G
   Increasing the Interpretability of Psychosis Models.
   Biol Psychiatry. 2025;97:99-101.
   PubMed        
   
   
3. PEARLSON GD
   Clinical Phenotypes Associated With White Matter Microstructural Abnormalities Across Early Psychoses.
   Biol Psychiatry. 2025;97:102-103.
   PubMed        
   
   

   
   Br J Psychiatry

4. TESLI N, Vaskinn A
   Violence and schizophrenia: let us take a deep breath and gain a meta-perspective.
   Br J Psychiatry. 2024;225:508-509.
   PubMed        
   
   

   
   Can J Psychiatry

5. ZIPURSKY RB
   Rethinking Schizophrenia-A Manageable Chronic Condition.
   Can J Psychiatry. 2024 Dec 10:7067437241301572. doi: 10.1177/07067437241301572.
   PubMed        
   
   

   
   Cereb Cortex

6. WU H, Chen X, Li Y, Zhao W, et al
   Impact of working memory training on brain network plasticity and genetic associations: insights from individual differences.
   Cereb Cortex. 2024;34:bhae445.
   PubMed         Abstract available
   
   

   
   J Clin Psychopharmacol

7. BUESKING SC, Kriz CR, Jarvis SP, Nelson LA, et al
   Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia: A Report of 3 Cases and Literature Review.
   J Clin Psychopharmacol. 2024 Dec 17. doi: 10.1097/JCP.0000000000001947.
   PubMed        
   
   

   
   Mol Psychiatry

8. LI X, Xue C, Zhu Z, Yu X, et al
   Application of GWAS summary data and drug-induced gene expression profiles of neural progenitor cells in psychiatric drug prioritization analysis.
   Mol Psychiatry. 2025;30:111-121.
   PubMed         Abstract available
   
   
9. XIA C, Alliey-Rodriguez N, Tamminga CA, Keshavan MS, et al
   Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations.
   Mol Psychiatry. 2024 Dec 21. doi: 10.1038/s41380-024-02876.
   PubMed         Abstract available
   
   
10. SOLMI M, Fornaro M, Caiolo S, Lussignoli M, et al
    Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis.
    Mol Psychiatry. 2024 Dec 18. doi: 10.1038/s41380-024-02733.
    PubMed         Abstract available
    
    
11. COHEN LS, Arakelian M, Church TR, Dunk MM, et al
    The phenomenology of postpartum psychosis: preliminary findings from the Massachusetts General Hospital Postpartum Psychosis Project.
    Mol Psychiatry. 2024 Dec 6. doi: 10.1038/s41380-024-02856.
    PubMed         Abstract available
    
    
12. MARQUES D, Vaziri N, Greenway SC, Bousman C, et al
    DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review.
    Mol Psychiatry. 2025;30:296-309.
    PubMed         Abstract available
    
    
13. CIULKINYTE A, Mountford HS, Fontanillas P, Bates TC, et al
    Genetic neurodevelopmental clustering and dyslexia.
    Mol Psychiatry. 2025;30:140-150.
    PubMed         Abstract available
    
    

    
    Nat Ment Health

14. KINSEY S, Kazimierczak K, Camazon PA, Chen J, et al
    Networks extracted from nonlinear fMRI connectivity exhibit unique spatial variation and enhanced sensitivity to differences between individuals with schizophrenia and controls.
    Nat Ment Health. 2024;2:1464-1475.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

15. GRENDAS LN, Olaviaga A, Chiapella LC, Daray FM, et al
    Incidence rate of suicidal behavior stratified by diagnosis among high-risk patients.
    Psychiatry Res. 2025;343:116310.
    PubMed         Abstract available
    
    
16. KHOODORUTH MAS, Hussain T, Ouanes S, Chut-Kai Khoodoruth NW, et al
    Peripheral inflammatory and metabolic markers as potential biomarkers in treatment-resistant schizophrenia: Insights from a Qatari Cohort.
    Psychiatry Res. 2024;344:116307.
    PubMed         Abstract available
    
    
17. GARCIA-FERNANDEZ L, Romero-Ferreiro V, Padilla S, Wynn R, et al
    Transcranial direct current stimulation (tDCS) enhances cognitive function in schizophrenia: A randomized double-blind sham-controlled trial.
    Psychiatry Res. 2024;344:116308.
    PubMed         Abstract available
    
    
18. MORITZ S, Leucht S, Hoyer L, Schmotz S, et al
    Towards the DSM-6: The intersection of OCD and psychosis. Expert perspectives on insight in the diagnosis of OCD.
    Psychiatry Res. 2024;344:116306.
    PubMed         Abstract available
    
    
19. SOURANDER A, Silwal S, Surcel HM, Hinkka-Yli-Salomaki S, et al
    Maternal vitamin B12 during pregnancy and schizophrenia in offspring.
    Psychiatry Res. 2024;344:116284.
    PubMed         Abstract available
    
    
20. PIETERS LE, Deenik J, Hoogendoorn AW, van Someren EJW, et al
    Sleep and physical activity patterns in relation to daily-life symptoms in psychosis: An actigraphy and experience sampling study.
    Psychiatry Res. 2024;344:116320.
    PubMed         Abstract available
    
    

    
    Psychol Med

21. FARES-OTERO NE, Verdolini N, Melero H, Andres-Camazon P, et al
    Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regions.
    Psychol Med. 2024 Dec 16:1-14. doi: 10.1017/S0033291724002393.
    PubMed         Abstract available
    
    
22. XU R, Zhang X, Zhou S, Guo L, et al
    Brain structural damage networks at different stages of schizophrenia.
    Psychol Med. 2024 Dec 11:1-11. doi: 10.1017/S0033291724003088.
    PubMed         Abstract available
    
    
23. STROMME MF, Thue Augustsson M, Bartz-Johannessen C, Stautland A, et al
    Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.
    Psychol Med. 2024 Dec 9:1-9. doi: 10.1017/S0033291724002873.
    PubMed         Abstract available
    
    
24. FROST R, Collier O, Hardy A
    Are trauma-related beliefs associated with psychosis symptoms? A systematic review and meta-analysis.
    Psychol Med. 2024 Dec 9:1-10. doi: 10.1017/S0033291724002629.
    PubMed         Abstract available
    
    

    
    Schizophr Res

25. POUGET JG, Cohen E, Ray JG, Wilton AS, et al
    Association between maternal schizophrenia and risk of serious asthma exacerbations in childhood.
    Schizophr Res. 2024;275:123-130.
    PubMed         Abstract available
    
    
26. LI J, Pang L, Liu F, Lu Z, et al
    Disentangling the topological symptom structure of schizophrenia: A network analysis.
    Schizophr Res. 2024;275:115-122.
    PubMed         Abstract available
    
    
27. ISHIZUKA M, Otsuka S, Miyata J, Yoshihara Y, et al
    Autism-spectrum quotient mediates the relationship between clinical symptoms and quality of life in schizophrenia.
    Schizophr Res. 2024;275:98-106.
    PubMed         Abstract available
    
    
28. DAVIES K, Lappin JM, Briggs N, Isobel S, et al
    Does shame mediate the influence of trauma on psychosis? A systematic review and meta-analytic structural equation modelling approach.
    Schizophr Res. 2024;275:87-97.
    PubMed         Abstract available
    
    
29. BRUNNER G, Gajwani R, Gross J, Gumley A, et al
    Choroid plexus morphology in schizophrenia and early-stage psychosis: A cross-sectional study.
    Schizophr Res. 2024;275:107-114.
    PubMed         Abstract available
    
    
30. JEFFREY C, Penney D, Sauve G, Mendelson D, et al
    Does metacognitive training for psychosis (MCT) improve neurocognitive performance? A systematic review and meta-analysis.
    Schizophr Res. 2024;275:79-86.
    PubMed         Abstract available
    
    
31. COLIJN MA
    16p11.2 duplication syndrome-associated psychosis: An illustrative case and review of the literature.
    Schizophr Res. 2024;275:76-78.
    PubMed        
    
    
32. ZURLO L, Dal Bo E, Gentili C, Cecchetto C, et al
    Olfactory dysfunction in schizophrenia and other psychotic disorders: A comprehensive and updated meta-analysis.
    Schizophr Res. 2024;275:62-75.
    PubMed         Abstract available
    
    
33. KIDD SA, D'Arcey J, Tackaberry-Giddens L, Asuncion TR, et al
    App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders.
    Schizophr Res. 2024;275:52-61.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.